Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing Covid-19. The company's CEO, Stephane Bancel, called it a "game changer." Shares ...
Hosted on MSN
Moderna's mRNA flu vaccine is more effective than the standard shot in a late-stage trial
The efficacy of flu shots is not always the same and it’s not always optimal. Some years, they can reduce the risk of illness by as little as 20% to 30%. Messenger RNA technology, or mRNA, is widely ...
Moderna’s messenger ribonucleic acid (mRNA) influenza vaccine is effective, but uncertainties remain, Food and Drug Administration reviewers said in a document released on June 16. Data from a Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results